Assembly Biosciences, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-42.8M | $-44.3M | $-28.5M | $-23.8M | $-19.4M | $-24.8M | $-34.3M | $-15.3M |
| Depreciation & Amortization | $219.0K | — | — | — | — | — | — | — |
| Depreciation | $200.0K | $80.0K | $65.0K | $11.0K | $6.2K | $4.6K | $3.7K | $12.5K |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $8.6M | $5.0M | $7.9M | $10.6M | $1.7M | $2.8M | $3.0M | $2.4M |
| Net Cash from Operating Activities | $1.9M | $-34.9M | $-18.7M | $-15.0M | $-17.8M | $-21.4M | $-25.1M | $-5.2M |
| Investing Activities | ||||||||
| Capital Expenditures | $865.0K | $147.0K | $58.3K | $150.0K | $6.5K | $3.2K | $12.0K | $0 |
| Business Acquisitions | — | $0 | $0 | $-509.4K | $0 | — | — | — |
| Net Cash from Investing Activities | $-15.6M | $36.2M | $-64.9M | $277.4K | $-6.5K | $-3.2K | $-12.0K | — |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | — | — | — | — | — | — |
| Net Cash from Financing Activities | $67.2M | $153.0K | $81.6M | $16.7M | $24.4M | $4.9M | $47.5M | $19.7M |
| Net Change in Cash | $53.5M | $1.5M | $-2.0M | $2.0M | $6.6M | $-16.5M | $22.4M | $14.5M |
| Free Cash Flow | $995.0K | $-35.0M | $-18.8M | $-15.1M | $-17.8M | $-21.4M | $-25.1M | $-5.2M |